Building resilience into clinical trial design and conduct during the pandemic

Updated guidance on “Building resilience into clinical trial design and conduct during the pandemic” has just been published on the MHRA Inspectorate blog. This guidance is now available to assist trial sponsors in building resilience into new and ongoing trials during the continuing pandemic.